Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gus A Baker

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Seizure|March 13, 2002
The effects of adjunctive topiramate therapy on seizure severity and health-related quality of life in patients with refractory epilepsy---a Canadian studyGus A Baker, Natalie G T Currie, Margaret J Light, et al.
Epilepsia|October 12, 2013
Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task ForceW Curt LaFrance, Gus A Baker, Rod Duncan, et al.
Neurologia I Neurochirurgia Polska|January 18, 2005
[Level of knowledge about epilepsy among Polish patients with epilepsy and their families in the European study SPOKE (Sanofi-Synthelabo Programme for Outcome Knowledge of Epilepsy)]Krystyna Niedzielska, Tomasz Wolańczyk, Gus A Baker, et al.
Epilepsy & Behavior : E&B|August 28, 2007
Nondrug treatments for psychogenic nonepileptic seizures: what's the evidence?Jayne L Brooks, Laura Goodfellow, Nynke M G Bodde, et al.
BMJ (Clinical Research Ed.)|November 18, 2008
What is the optimal management of partial epilepsy uncontrolled by a first choice anticonvulsant?David W Chadwick, Gus A Baker, Ann Jacoby, et al.
Seizure|November 28, 2022
The WHO intersectoral global action plan and epilepsy cascade target: Towards a roadmap for implementationSebastian F Winter, Donna Walsh, Action Amos, et al.
Epilepsia|November 13, 2010
Factors predictive of resilience and vulnerability in new-onset epilepsyJoanne Taylor, Ann Jacoby, Gus A Baker, et al.
The Cochrane Database of Systematic Reviews|October 8, 2010
WITHDRAWN: Self-management education for children with epilepsyTim Stokes, Elizabeth J Shaw, Janette Camosso-Stefinovic, et al.
Epilepsia|January 30, 2015
Quality-of-life outcomes of initiating treatment with standard and newer antiepileptic drugs in adults with new-onset epilepsy: findings from the SANAD trialAnn Jacoby, Maria Sudell, Catrin Tudur Smith, et al.
Epilepsy & Behavior : E&B|October 13, 2012
The stigma of people with epilepsy is demonstrated at the internalized, interpersonal and institutional levels in a specific sociocultural context: findings from an ethnographic study in rural ChinaWencui Guo, Jianzhong Wu, Wenzhi Wang, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Seizure|March 13, 2002
The effects of adjunctive topiramate therapy on seizure severity and health-related quality of life in patients with refractory epilepsy---a Canadian studyGus A Baker, Natalie G T Currie, Margaret J Light, et al.
Epilepsia|October 12, 2013
Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task ForceW Curt LaFrance, Gus A Baker, Rod Duncan, et al.
Neurologia I Neurochirurgia Polska|January 18, 2005
[Level of knowledge about epilepsy among Polish patients with epilepsy and their families in the European study SPOKE (Sanofi-Synthelabo Programme for Outcome Knowledge of Epilepsy)]Krystyna Niedzielska, Tomasz Wolańczyk, Gus A Baker, et al.
Epilepsy & Behavior : E&B|August 28, 2007
Nondrug treatments for psychogenic nonepileptic seizures: what's the evidence?Jayne L Brooks, Laura Goodfellow, Nynke M G Bodde, et al.
BMJ (Clinical Research Ed.)|November 18, 2008
What is the optimal management of partial epilepsy uncontrolled by a first choice anticonvulsant?David W Chadwick, Gus A Baker, Ann Jacoby, et al.
Seizure|November 28, 2022
The WHO intersectoral global action plan and epilepsy cascade target: Towards a roadmap for implementationSebastian F Winter, Donna Walsh, Action Amos, et al.
Epilepsia|November 13, 2010
Factors predictive of resilience and vulnerability in new-onset epilepsyJoanne Taylor, Ann Jacoby, Gus A Baker, et al.
The Cochrane Database of Systematic Reviews|October 8, 2010
WITHDRAWN: Self-management education for children with epilepsyTim Stokes, Elizabeth J Shaw, Janette Camosso-Stefinovic, et al.
Epilepsia|January 30, 2015
Quality-of-life outcomes of initiating treatment with standard and newer antiepileptic drugs in adults with new-onset epilepsy: findings from the SANAD trialAnn Jacoby, Maria Sudell, Catrin Tudur Smith, et al.
Epilepsy & Behavior : E&B|October 13, 2012
The stigma of people with epilepsy is demonstrated at the internalized, interpersonal and institutional levels in a specific sociocultural context: findings from an ethnographic study in rural ChinaWencui Guo, Jianzhong Wu, Wenzhi Wang, et al.
Pageof 12